Verition Fund Management LLC Pmv Pharmaceuticals, Inc. Transaction History

Verition Fund Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.51 - $3.12 $2.08 Million - $4.3 Million	-1,379,549 Reduced 87.29%	200,938 $341,000
Q4 2023 Feb 14, 2024	SELL	$1.23 - $6.6 $1.09 Million - $5.85 Million	-885,901 Reduced 35.92%	1,580,487 $4.9 Million
Q3 2023 Nov 14, 2023	BUY	$6.01 - $8.93 $614,173 - $912,574	102,192 Added 4.32%	2,466,388 $15.1 Million
Q2 2023 Aug 14, 2023	BUY	$3.94 - $6.27 $854,369 - $1.36 Million	216,845 Added 10.1%	2,364,196 $14.8 Million
Q1 2023 May 15, 2023	BUY	$4.77 - $9.16 $6.56 Million - $12.6 Million	1,376,092 Added 178.42%	2,147,351 $10.2 Million
Q4 2022 Feb 14, 2023	BUY	$8.17 - $12.95 $5.12 Million - $8.12 Million	627,113 Added 435.05%	771,259 $6.71 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $1.08 Million - $1.63 Million	94,678 Added 191.39%	144,146 $1.72 Million
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $456,589 - $1.11 Million	49,468 New	49,468 $705,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.